Angiopoietin‐2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N‐terminal pro‐brain natriuretic peptide

BACKGROUND: Using circulating biomarkers as a noninvasive method to assist the evaluation of coronary artery disease (CAD) is beneficial for reducing the unnecessary diagnostic cardiac catheterization. This study aimed to assess the predictive role of angiopoietin‐2 (Ang‐2) for the presence of obstructive coronary stenosis as compared with N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) in patients with symptoms of CAD. METHODS: The study enrolled 222 consecutive symptomatic patients who underwent elective diagnostic cardiac catheterization from July to December 2018. Blood samples were collected in the first morning after admission. The severity of coronary stenosis was assessed by coronary angiography. The obstructive CAD was defined as stenosis ≥50% of the left main coronary artery or stenosis ≥70% of a major epicardial vessel (left anterior descending artery, left circumflex artery and right coronary artery). RESULTS: Patients with obstructive CAD (n = 120) had significantly higher levels of Ang‐2 and NT‐proBNP compared with those without. In multivariable regression analysis, only NT‐proBNP levels were independently associated with Ang‐2 levels. NT‐proBNP was superior to Ang‐2 as a predictor for the presence of obstructive CAD (NT‐proBNP, area under curve [AUC] = 0.733, vs Ang‐2, AUC = 0.626, P = 0.004). In multiple logistic regression analysis, NT‐proBNP, but not Ang‐2, was the independent predictor of obstructive CAD. The combination of Ang‐2 with NT‐proBNP did not provide the incremental value over NT‐proBNP alone. CONCLUSION: Serum Ang‐2 levels are associated with NT‐proBNP levels in patients suspected for CAD. NT‐proBNP is superior to Ang‐2 as a predictor for the presence of obstructive CAD. However, Ang‐2 does not further increase diagnostic accuracy on top of NT‐proBNP.